Anhui Anke Biotechnology Hits Day High with Strong 3.54% Intraday Surge

Anhui Anke Biotechnology (Group) Co., Ltd. has experienced a notable increase of 3.54% on August 13, 2026, reaching an intraday high of CNY 8.96. This performance stands in contrast to the China Shanghai Composite, which declined by 0.5% on the same day. Over the past week, Anhui Anke has shown a robust gain of 7.07%, further highlighting its recent upward momentum. Despite the positive short-term performance, the company has faced challenges over the longer term. Over the past year, Anhui Anke's stock has decreased by 26.16%, and it has underperformed the benchmark index consistently for the last three years. The company's market capitalization is CNY 9,879 million, and it operates within the Pharmaceuticals & Biotechnology sector. Key financial metrics indicate a return on equity of 14.76% and a price-to-book ratio of 2.08. The stock also offers a dividend yield of 2.93%. While the recent gains are noteworthy, the company has shown flat results in its latest quarterly performance, with net sales recorded at CNY 541.72 million.